Loading
Latest filing published 17 Mar 2026 for Armata Pharmaceuticals, Inc., €9,422.
Pierre Kyme appears in our data through filings on Armata Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 14 March 2025 to 14 March 2026.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The newest entry dates from 17 March 2026: a share grant of €9,422, in Armata Pharmaceuticals, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations